The use of immunotherapy (IT) in cancer has recently resulted in impressive responses. Yet, the usages of IT regimens, especially those involving cytokine therapies, have also resulted in the in duction of severe systemic toxicities often not pre viously characterized in their preclinical animal studies. Because such toxicities often require inten sive care management of patients, the causes for the discrepancies in observations between clin ical and preclinical toxicity merit further study.
study seeks to establish the consequences of increased adipose tissue accumulation throughout aging upon ITinduced tox icities. Here, we find that adiposity results in a skewing toward increased levels of proinflammatory M1 macrophages within the peritoneal cavity and visceral adipose tissues that ultimately result in heightened production of proinflammatory cytokines, namely TNF, during strong immune stimulation with IT. Importantly, aged ad libitum (AL)-fed mice and young obese mice succumb to TNFmediated pathological responses culmi nating in rapid lethality, which are prevented through caloric restriction in the aged or through either macrophage depletion or TNF blockade.
RESULTS

IT administration in the aged results in rapid lethal cytokine storm and is associated with increased accumulation of visceral adipose tissue
The combination IT regimen consisting of CD40 and IL2 (CD40/IL2) has previously shown synergistic antitumor effects resulting in the regression of metastatic tumors in young (<6 mo) mouse models (Murphy et al., 2003) . Re cently, we demonstrated that administration of the therapeu tic dose (high dose [HD] ) of CD40/IL2 into aged mice (≥15 mo) resulted in a heightened cytokine storm that prompted multiorgan damage and resulted in 100% lethality by day 2 of treatment (Bouchlaka et al., 2013) . To address whether the increased lethality was specific to this therapeutic dosage in the aged, we administered CD40/IL2 at a lower dose (LD), less than half, into aged ALfed mice. Consistent with our previous findings, treatment of aged mice with LD IT re sulted in 100% mortality by day 2 of treatment ( Fig. 1 A) and demonstrated increased serum levels of proinflammatory cy tokines TNF, IL6, and IFN, indicative of a cytokine storm (Fig. 1 B) . In addition, to ensure that the lethality observed in the aged mice was not IT regimen-specific, we administered an IT combination of CpG and IL2 (CpG/IL2) into young WT and aged AL mice. Confirming our previous findings, aged mice treated with CpG/IL2 therapy incurred a similar cytokine storm that culminated in rapid lethality by day 3 (Fig. 1 , C-E), in contrast to young mice which exhibited lower levels of cytokines and demonstrated complete treatment tol erance (Fig. 1, C 
-E).
Normal aging is inherently associated with changes in body mass composition-specifically with decreases in muscle mass and increases in intraabdominal visceral adiposity (Harris, 2002) . Equally, within our animal studies an observable differ ence between aged and young mice is noted in overall size, in particular increased waist circumference (Fig. 1 F) . On average, aged mice weigh twice as much as young (Fig. 1 G) . To deter mine whether the difference in size is due to increases in fat deposits, we sought to quantify differences in body mass and the presence of visceral adiposity. Young (<6 mo) and aged (≥15 mo) C57BL/6 mice were analyzed through magnetic resonance imaging (MRI) to quantify the presence of visceral adiposity. Aged mice exhibited markedly increased body mass indices and total visceral fat volumes in comparison with young diversity, increases in genomic instability, and increases in cel lular senescence (Campisi, 2013) . However, despite the ma jority of patients being of this demographic, the overwhelming majority of preclinical studies are performed in young inbred mice. We recently demonstrated that treatment of young mice with a combination IT regimen consisting of agonistic mono clonal antibody to CD40 (CD40) given in conjunction with IL2 resulted in synergistic antitumor effects and was well tolerated (Murphy et al., 2003) . Yet, administration of the same regimen in an aged cohort resulted in 100% lethality within two days of treatment (Bouchlaka et al., 2013) . Importantly, the mortality in the aged was perpetuated by an aberrant cytokine storm mirroring a systemic inflammatory response syndrome (SIRS), which resulted in multiorgan damage (Bouchlaka et al., 2013) . These systemic toxicities were closely representative of those previously noted clinically with FDAapproved immu nostimulatory IT therapeutics such as highdose IL2 and IFN (Lee and Margolin, 2011) .
Aging is associated with a gradual decline in immunolog ical function but is also accompanied by the coincidence of a systemic, chronic, and lowgrade proinflammatory response termed inflammaging that leads to increased systemic cyto kine levels, namely IL1, IL6, and TNF (Franceschi, 2007) . Emerging data suggests that inflammaging may be influenced by ageassociated changes in body mass composition such as decreased lean muscle mass, increased adiposity, and increases in overall body mass index (BMI; Franceschi et al., 2000) . Whether adiposity plays a role in the generation of systemic toxicities or whether it is primarily an ageassociated occur rence remains unknown.
Like aging, hallmark to the obese microenvironment is the development of a lowgrade chronic "metainflammatory" state. Excess adiposity is associated with increased infiltration of macrophages and proinflammatory mediators such as den dritic cells, NK cells, and T cells into fat depots that ultimately results in environmental remodeling. Consequences include increased circulating levels of Creactive protein (CRP), IL6, leptin, and TNF (Ronti et al., 2006; VázquezVela et al., 2008) . Importantly, the immunomodulatory effects of increased adi pose tissue extends through the ability for both adipocytes and the stromal vascular fraction to express a variety of immunologi cally important surface receptors, such as the leptin receptor, IL6 receptor, and both p55 and p75 TNF receptors (Ailhaud, 2000) . Systemic consequences of increased adiposity are also seen at distance sites through premature induction of aging associated changes such as thymic involution, which leads to the restriction of naive T cell output and ultimately restriction of the T cell repertoire (Yang et al., 2009) .
Collectively, the field of IT has made great progress in the last decade toward the development of therapeutic candidates against cancer. Yet, these candidates have been met in the clinic with the induction of severe, often limiting, systemic toxici ties that hinder their usage. Additionally, given the rise of obesity within society, as well as the estimation that cancer is a disease primarily of the aged, using lean and young models may not accurately reflect patient outcomes. Therefore, this were similar to young mice (Fig. 1, G-I ). MRI scans of young (4 mo), middleaged (9 mo), and aged (15 mo) mice that were either ALfed or CR throughout life showed significant dif ferences in adipose accumulation over time (Fig. 1 I) . We found that with increasing age, ALfed mice have a proportional in crease in body fat content, whereas mice placed on a CR diet lack increased fat accumulation regardless of age. Aged CR mice show no significant difference in fat volume ratios to their middleage and young counterparts, and remain similar to young AL mice (Fig. 1 I) .
Caloric restriction in aged mice results in decreased accumulation of adiposity and protection from IT-induced toxicity To examine the effect of adiposity and aging on the develop ment of systemic toxicities after IT, aged AL, aged CR, and young AL mice were administered IT or a control therapy mice (Fig. 1, G and I) . These results indicate that aged mice are not only heavier and larger in size but that these size differences are attributed to increases in adipose tissue accumulation.
Adipose tissue is widely published to be a highly active metabolic organ with immune modulatory capabilities. To address whether in our aged ALfed mice, who were allowed to freely access food, the increased adiposity noted was con tributory toward the development of ITinduced toxicities in the aged, we aimed to determine the effects of IT administra tion into an aged calorierestricted (CR) cohort. CR mice are placed on a food restriction diet beginning at 14 wk of age and maintained throughout life. To ensure that agematched CR aged mice contained a decreased accumulation of body fat in comparison with aged AL mice, we quantified total body weight and visceral fat through MRI (Fig. 1, H and I ). CR mice weighed significantly less than AL aged mice and exhib ited a decreased presence of visceral adiposity to levels that WS is indicative of water suppression, where fat is bright. FS is indicative of fat suppression, fat is dark/black. Data in all panels are representative of one of at least five experiments with similar results. MRI scans are representative of one of at least three mice imaged per group with similar results. Survival analysis was plotted according to the Kaplan-Meier method, and statistical differences were determined with the log-rank test. Bar graph (mean value ± SEM) statistics were performed using either one-way or two-way ANOVA with Bonferroni post-hoc tests. ***, P < 0.001; **, P < 0.01; *, P < 0.05. succumb to mortality on day 2 of treatment ( Fig. 2 G) . How ever, 100% of aged CR mice placed on the HD amount of IT demonstrated complete protection from CD40/IL2-mediated lethality (Fig. 2 G) . Collectively, these data suggest that increased body fat plays a critical role in the induction of systemic toxicities by IT. Increased adiposity played a critical role in the ageassociated cytokine storm and subsequent organ pathologies after IT and calorie restriction diminished the de velopment of such toxicities conferring a protective effect that allowed for increased survival in the aged.
Increased adipose tissue accumulation through obesity, in the absence of age, results in IT-induced lethal cytokine storm To further dissect the role of adipose tissue in the ITassociated inflammatory responses seen in aged mice, we next sought to determine the impact of adiposity, in the absence of age, as a possible cofactor. Young ob/ob mice (B6.CgLep ob/ob ) are leptin deficient and therefore start exhibiting obesity by 3 wk of age. In comparison to agematched young WT (2 mo) control mice placed on an AL diet (young AL), ob/ob mice have significantly higher body masses and weigh, on average, 2.5× greater (Fig. 3 A) . MRI analysis of body fat content demonstrated (rIgG/PBS). IT resulted in increased lymphocytic infiltrates to the liver of aged CR and aged AL mice, in contrast to age matched controltreated mice (Fig. 2 , A-C). To assess whether IT resulted in organ damage, livers and intestines were col lected on day 2 of treatment, the day of mortality in aged AL mice, and assessed for pathological changes. Importantly, livers and intestines from aged CR mice demonstrated significantly less inflammation and less necrosis in comparison with aged AL mice (Fig. 2 , A and C). Serum analysis of alanine amino transferase (ALT) enzyme levels, a correlate of liver damage, showed a significant reduction in ALT levels in aged CR mice in comparison with aged AL mice (Fig. 2 B) . Additionally, serum proinflammatory cytokine analysis of TNF (Fig. 2 D) , IL6 ( Fig. 2 E) , and IFN ( Fig. 2 F) resulted in all cytokines being significantly decreased in aged CR mice in comparison with the aged AL mice. These decreases in cytokine values were to levels that were either lowerthan or aslowas those in young AL mice that received IT (Fig. 2 , D-F). To determine if these lower cytokine values during IT therapy would confer protec tion against ITinduced mortality, aged AL mice and aged CR mice were administered either LD IT or HD IT and monitored for mortality. Independent of treatment dose, aged AL mice all All data panels are representative of one of four independent experiments with similar results for all panels. Survival analysis was plotted according to the Kaplan-Meier method and statistical differences were determined by using the log-rank test. Bar graph (mean value ± SEM) statistics were performed using one-way ANOVA with Bonferroni post-hoc test. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01. JEM Vol. 211, No. 12 Ar ticle 2377 was comparable to the aged AL mice and significantly greater than the young AL (Fig. 3, C and D) .
Because HD IT resulted in significant changes within the obese ob/ob mice, we next administered the lower dose (LD) of IT to young ob/ob, young agematched AL mice, aged AL, and aged CR mice. Administration of LD IT still resulted in significant increases in TNF and IL6 proinflammatory cyto kine levels within the young ob/ob that were not significantly different to the aged AL mice (Fig. 3, E and F) . Both ob/ob and aged AL were significantly greater than both the young AL and aged CR mice, where CR in the aged led to significant downregulation in both TNF and IL6 cytokine production (Fig. 3, E and F) . Although the young ob/ob and the aged AL mice displayed increased levels of IFN, these levels were not significant among the groups (Fig. 3 G) . Consistent with the increase in proinflammatory cytokines at day 2 of IT treatment, 100% of young ob/ob mice succumbed to ITinduced lethality within 4 days of treatment in contrast to 100% survival in the that young ob/ob mice have higher total body fat content that is similar in accumulation to the aged mice, being deposited largely in the intraabdominal cavity, in comparison with young AL mice (Fig. 3 B) .
To determine if adiposity could solely induce toxic con sequences in aged AL, young ob/ob and agematched young AL mice were treated with HD IT and at day 2 of treatment analyzed for the presence of immunemediated organ patholog ical changes within the liver and intestines (Fig. 3, C and D) . IT resulted in mild inflammatory infiltrates in young AL mice but resulted in moderate to severe inflammation in the ob/ob mice, which was comparable to the aged within the intestines (Fig. 3 D) . Yet, analysis of ITinduced liver pathology was hin dered by the presence of extensive steatosis in ob/ob mice, re sulting in a paradoxical interference in determining the intensity of immunemediated inflammatory liver damage (Fig. 3 C) . IT resulted in both the intestines and liver displaying the most immunemediated inflammatory damage within the ob/ob that (E-G) Young AL (2 mo), young ob/ob (2 mo), aged AL (18 mo), and aged CR (18 mo) were treated with LD CD40/IL-2 and serum was collected day 2 of treatment and analyzed by CBA for levels of: TNF (E), IL-6 (F), and IFN- (G), n = 3 mice/group. (H and I) Young AL (2 mo), young ob/ob (2 mo), aged AL (18 mo), and aged CR (18 mo) were treated with LD CD40/ IL-2 (H) or CpG/IL-2 (I) or rIgG/PBS control and survival was monitored. (J) Serum levels of TNF were measured on day 2 of CpG/IL-2 therapy by CBA. Data in all panels are representative of one of at least three experiments with similar results. MRI scans are representative of at least three mice imaged per group with similar results. Survival data were plotted using the Kaplan-Meier method and statistical differences were determined with the log-rank test. Bar graph (mean value ± SEM) statistics performed using Student's t test or one-way ANOVA with Bonferroni post-hoc tests. ***, P < 0.001; **, P < 0.01; *, P < 0.05.
This data further supports that increased adiposity plays a crucial role in the induction of systemic toxicities after IT. These data are suggestive that not only does an aging environ ment result in lethal toxicities but toxicity may also be depen dent on the increase in fat accumulation as the young ob/ob mice succumb to cytokine storm induction and mortality after IT, similar to that observed in the aged mice.
IT toxicity is TNF-and M1 macrophage-dependent within the peritoneum and visceral adipose tissues A hallmark of obesity is the increasing infiltration of macro phages into adipose tissues (ATMs) through the secretion of MCP1 by adipocytes. Phenotypically, these macrophages are young WT cohort (Fig. 3 H) . 100% of aged AL mice yielded to lethality from the IT by day 2 of treatment, whereas 100% of aged CR mice survived the entire regimen (Fig. 3 H) .
The pathological and lethal response observed within the young ob/ob mice was not CD40/IL2 IT administration specific. Young AL and agematched young ob/ob mice were administered CpG in combination with HD IL2 and, like wise, resulted in lethality of 75% of young ob/ob mice by day 5 of treatment but resulted in complete tolerance by young AL mice (Fig. 3 I) . CpG/IL2 therapy led to significantly in creased levels of serum proinflammatory cytokine TNF in an analogous trend as CD40/IL2 administration on day 2 of therapy ( Fig. 3 J) . Visceral adipose tissue and peritoneal lavages were collected on day 2 and assessed for the presence of macrophages identified as CD45 + CD19  F4/80 + CD11b + . Ratio of M1/M2 macrophages (A), and total numbers (B) and percentages (C) of TNFproducing macrophages. Macrophages identified as M1 macrophages were characterized as CD206  ; M2 macrophages were gated as CD206 + . (E-H) Young AL (2 mo) and young ob/ob (2 mo) were treated with either control or macrophage depleting clodronate liposomes before and during LD CD40/IL-2 and survival was monitored; n = 5 mice/group. (F and G) On day 2, visceral adipose tissues and peritoneal lavages were collected and assessed for the percentages TNF + macrophages (F and G) as characterized in experiments in A-D and serum TNF levels (H), n = 4 mice/group. (I-L) Young AL (2 mo) and young ob/ob (2 mo) mice were treated with either control hIgG/PBS or subcutaneous injection of 1.5 mg/0.1 ml etanercept before and during LD CD40/ IL-2 and survival was monitored (I), n = 5 mice/group. (J and K) On day 2, visceral adipose tissue and peritoneal lavages were collected and assessed by flow cytometry for the percentages of TNF + macrophages (J and K) and serum TNF levels (L); n = 4 mice/group. Data in all panels are representative of one of at least three experiments with similar results. Survival data were plotted using the Kaplan-Meier method and statistical differences were determined with the log-rank test. Bar graph (mean value ± SEM) statistics performed using one-way ANOVA with Bonferroni post-hoc tests. **, P < 0.01; *, P < 0.05. (Fig. 4, I-L) . Both macrophage depletion and cotreatment with etanercept during LD CD40/IL2 resulted in complete protection of young ob/ob mice from lethality (Fig. 4, E and I ). As expected, treatment with liposomal clodronate led to signif icantly decreased levels of TNFproducing macrophages within both the visceral fat and peritoneal lavages (Fig. 4, F and G) , which significantly reduced systemic circulating serum levels of proinflammatory cytokine TNF (Fig. 4 H) . Additionally, coadministration of LD CD40/IL2 with etanercept did not reduce the percentages of TNFexpressing macrophages within the visceral fat or peritoneal cavity (Fig. 4 , J and K) but mediated complete protection through an overall reduction in systemic TNF levels (Fig. 4 L) .
Together, these data indicate that proinflammatory M1 macrophages are the cellular mediator in the induction of IT toxicity, particularly through increased presence within the peri toneal and visceral adipose tissues. Importantly, these effects are TNFdependent, as blocking TNF levels either through etan ercept administration or macrophage depletion resulted in com plete protection of young ob/ob mice from lethality.
Diet-induced obese (DIO) mice succumb to cytokine storm, organ pathology, and lethality similar to ob/ob and aged AL mice after IT ob/ob mice are congenic for the spontaneous mutation in the OB gene, resulting in leptin hormone deficiency. To extend our findings, we generated young DIO mice. Mice were placed on a purified 60% fat diet to induce obesity beginning at 3 wk of age and were determined to be obese when weighing >40 g (DIO). Agematched counterparts were placed on a matching predominately classically activated M1 cells that also express proinflammatory mediators IL1, TNF, and IL6 (Lumeng et al., 2007; Fujisaka et al., 2009 ). As such, we next sought to determine if increases in M1 macrophages within the perito neal cavity and visceral adipose tissues could account for the pathological increases in systemic TNF during IT administra tion. Young AL and agematched young ob/ob mice were ad ministered LD CD40/IL2. At day 2 of treatment, visceral adipose tissues and peritoneal lavages were phenotypically as sessed by flow cytometry for the presence of M1 (CD206  ) macrophages, M2 (CD206 + ) macrophages, and percentages of TNFexpressing macrophages. Consistently, young ob/ob mice demonstrated significant increases in M1 macrophage proportions during IT administration, whereas young AL mice were able to maintain consistent M1toM2 ratios (Fig. 4 A) . Additionally, both the visceral adipose tissues and peritoneal lavages of ob/ob mice experienced significant increases in per centages of TNFexpressing macrophages as opposed to young AL mice (Fig. 4, B-D) . Significant changes were not observed in the spleen of either young ob/ob or AL mice (unpublished data). This data, consistent with obesity literature, suggests that increases in adipose tissue accumulation within the visceral cavity may impact regulation of M1 and M2 macrophage ra tios that ultimately may affect TNF responses to immune stim ulation with immunotherapeutic regimens.
Given the increases in M1 macrophages within the obese mice and dysregulation observed with IT, young ob/ob and young AL mice were treated with LD CD40/IL2 in conjunc tion with either liposomal clodronate for macrophage deple tion (Fig. 4, E-H . DIO succumb to cytokine storm, organ pathology, and lethality similar to aged AL mice after IT. Young C57BL/6 mice were placed on a 60% fat diet starting at 3 wk of age to induce obesity (young DIO). Lean age-matched controls (young lean) were fed a 10% fat diet beginning at 3 wk of age. Young mice were analyzed at 5 mo of age, and aged AL mice were analyzed at 18 mo of age, n = 6 mice/group. Average body weight (A), representative pictures (B), and total fat content as measured by MRI (C) are shown for each group. (D-F) Young lean (5 mo), young DIO (5 mo), and aged AL (18 mo) mice were treated with HD CD40/IL-2 or rIgG/PBS. Serum was collected day 2 after the start of treatment and analyzed by CBA for levels of TNF (C), IL-6 (D), and IFN- (E) and survival was analyzed (F). Data in A-C are representative of one of at least three experiments with similar results and data in D-G are representative of one of at least four experiments with similar results. Survival data were plotted using the Kaplan-Meier method and statistical differences were determined with the log-rank test. Bar graph (mean value ± SEM) statistics performed using one-way ANOVA with Bonferroni post-hoc tests. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05.
were observed between young obese and aged AL mice, where aged mice die by day 2 but young obese mice die at day 4 of treatment. Therefore, although our data strongly demonstrates that adiposity plays a central role in the induction of toxicities, aging is also a likely key factor. Therefore, our findings high light the importance in considering both the status of aging and obesity of patients receiving systemic administration of stim ulatory IT regimens. It will be important to conduct studies dissociating the consequences of aging upon increased cytokine responsiveness, possibly through either investigating epigene tic modifications induced by the metainflammatory and/or inflammaging states associated with increased adipose accumu lation or whether aging is accompanied by changes in expres sion levels of various receptors that allow for a quicker response.
The development of IT regimens continues on a positive trajectory with increasing successes within a variety of can cers. Active IT has taken a greater comprehensive form focus ing on activating humoral and cellmediated immunity, and these strategies have included antigenspecific vaccines (i.e., MART1 vaccines), DCbased vaccines (i.e., SipuleucelT), inhibitors of checkpoint blockade (i.e., CTLA4 and PD1), and systemic stimulatory regimens through cytokine based therapies and application of agonistic antibodies (i.e., CD40, IFN, and IL2). Our data presented herein demonstrates that both young obese and aged AL mice succumb to rapid lethality during systemic administration of stimulatory thera pies. Our data strongly suggests that excess adiposity may be a prognostic factor in determining patient outcome and treat ment tolerance. However, additional studies need to be con ducted examining the effects of adiposity on the development of adverse reactions within other classes of IT regimens, such as checkpoint inhibitors.
Clinically, we hypothesize that taking into account patient BMI, adipose accumulation, and age may better modulate treat ment type choices as well as the inclusion of supportive thera peutics such as TNF blockade in conjunction with anticancer therapies that, overall, may increase patient survival and lead to greater anticancer responses. Followup investigations in tumorbearing models merit further study.
MATERIALS AND METHODS
Animals and diets.
Female young (2-5 mo old), middleaged (9-12 mo old), and aged (15-22 mo old) C57BL/6 mice were purchased from Charles River or from the animal production area at the National Cancer Institute. Young female B6.CgLep ob/ob and young agematched female WT control C57BL/6 mice were purchased from The Jackson Laboratory at 8-12 wk of age.
DIO obese and control lean mice were generated from WT C57BL/6 mice purchased at 3 wk of age from Charles River or from the animal produc tion area at the National Cancer Institute. Mice were placed on an opensource purified diet consisting of either 60% highfat (D12492) or 10% lowfat (D12450J) constitution (Research Diets, Inc.). Agematched mice were placed on either a highfat or lowfat diet beginning at 3 wk of age for 16-20 wk and weighed weekly. Mice were deemed obese upon reaching a minimum of 40 g of weight.
For studies comparing aged AL and CR dietary effects, both female aged CR and agematched female ALlittermates (15-22 mo old) were purchased from the CR rodent colony at the National Institutes on Aging, National In stitutes of Health (NIH). In brief, mice were either raised through free access, AL, feeding on the NIH31 regular chow, or placed on a limited daily feeding purified diet that was 10% fat and served as lean controls. In creases in body mass were validated in DIO mice before IT administration (Fig. 5, A-C) . DIO mice displayed increases in overall body weight and size (Fig. 5, A and B) . MRI analysis of body fat content showed increased total body fat accumu lation, largely as increased visceral fat, in young DIO mice that was similar to the aged AL mice (Fig. 5 C) .
Confirming our previous findings, DIO mice treated with HD CD40/IL2 displayed increased serum TNF, IL6, and IFN levels compared with agematched young mice on a 10% fat diet after IT administration (Fig. 5, D-F) . The increases in proinflammatory cytokines in DIO mice were lower, yet not significantly so, than aged mice after IT (Fig. 4, C-E) . Young DIO mice started succumbing to IT lethality at day 3 of treat ment (>60%), and <40% were still alive by day 4 (Fig. 5 G) .
Together, these results suggest that adipose tissue is a criti cal component to the development of systemic cytokine storm and lethality after IT. Yet, due to the observation that treatment of DIO mice did not result in 100% of mice succumbing to lethality, aging itself may also likely contribute to the overall heightened inflammatory responses incurred by IT.
DISCUSSION
After initiation of strong immune stimulation with IT, we show that both young obese and aged AL mice demonstrate increased levels of adiposity, which led to aberrant increases in both TNF and IL6 levels that ultimately resulted in multi organ damage. Similar to aging, obesity has been shown to be immunomodulatory, where the cross talk between adipocytes and macrophages is thought to lead toward the development and perpetuation of a metainflammatory state through con tinual NFB activation, which is currently hypothesized to be responsible for the induction of metabolic diseases. A study conducted by Spaulding et al. (1997) examined the effects of age and calorie restriction on the production of TNF and IL6 in resting mice and demonstrated that serum levels of both cytokines were significantly higher in aged mice in compari son to young, and yet aged mice subjected to longterm calo rie restriction resulted in TNF and IL6 serum levels that were comparable to the young mice. These findings lend sup port to the protective effects seen within our studies in the aged CR cohort administered IT.
Importantly, the data presented here demonstrate the need for using age and body fat content as variables in preclinical assessment of therapeutics and modeling diseases, such as can cer. However, the vast majority of inbred mouse studies are housed in specific pathogenfree colonies where normal aging may result in higher body fat content and yet less immune challenge from pathogens making them more susceptible to proinflammatory responses and toxicities after immune thera pies. It will therefore be important that future studies ascer tain responses in mice that have been exposed to pathogens and immune challenges as they age.
Furthermore, our data demonstrate that an obese phenotype resulted in lethal consequences that were ameliorated through calorie restriction in the aged. Also, differences in lethality Murine macrophage studies. On day 2 of treatment, murine macrophages were isolated from either the peritoneal cavity or visceral adipose tissue. For peritoneal lavages, 4 ml of cold PBS was injected into the peritoneal cavity of each mouse and then aspirated. Lavages were spun down at 1,200 rpm for 5 min and the resulting pellet was resuspended in RF10c media and plated for flow cytometry staining.
The stromal vascular fraction of visceral adipose tissues was collected day 2 of treatment. Adipose tissues from the visceral cavity (gonadal) were col lected and then incubated for 60 min in a digestion solution consisting of 2 mg/ml type IV collagenase (SigmaAldrich) dissolved fresh in a 2% BSA in PBS solution. After incubation samples were centrifuged at 1,200 rpm for 5 min for layer separation of the stromal vascular fraction from adipocytes. The resulting stromal vascular fraction was then removed, resuspended into a single cell suspension, counted, and plated for flow cytometry staining.
Flow cytometry analysis of macrophages. Single cell suspensions from the peritoneal lavages and visceral adipose tissues were plated in RF10c media with the addition of GolgiPlug (containing Brefeldin A) and GolgiStop (con taining Monensin) Protein Transport Inhibitors (BD) according to manufac turer's protocols. Plates were incubated for 9 h at 37°C and 5% CO 2 .
After incubation, cells were washed with PBS and stained for flow analy sis. Single cell suspensions were labeled with Fc block (purified anti-mouse CD16/32; BD) for 10 min, followed by labeling with antibodies for 20 min at 4C. Cells were washed twice with a staining buffer consisting of 5% FBS (Gemini Bioproducts) in DPBS (Corning). For intracellular staining, the Cytofix/Cytoperm kit (BD) was used per manufacturer's protocols. After staining, cells were analyzed using a custom configured Fortessa cytometer, and by using FACSDiva software (BD). Data were analyzed using FlowJo software vX (Tree Star). Antibodies used to distinguish macrophages were: PBconjugated anti-mouse CD45, BV711conjugated anti-mouse CD11b, BV605 and PEconjugated anti-mouse CD206, BV785conjugated antimouse CD19, APCconjugated anti-mouse F4/80, and PECy7-conjugated anti-mouse TNF (BioLegend).
Serum cytokine bead array. Serum levels of TNF, IFN, and IL6 were quantified by multiplex measurement using the Cytometric Bead Array (CBA; BD) kit as described previously (Bouchlaka et al., 2013) . In brief, serum samples and standards were incubated for 1 h at 25°C with a bead mixture containing bound antibodies to TNF, IFN, and IL6 according to manufacturer's instructions. Samples and standards were resuspended in wash buffer and analyzed by flow cytometry. Data were acquired on a custom configured Fortessa cell analyzer using FACSDiva software (BD) and analyzed using FlowJo software (Tree Star). Each sample was analyzed in triplicate. Upon analysis of raw data, the mean fluorescent intensities (MFIs) of each bead cluster were quantified. Where indicated in the figures, protein concen trations were extrapolated relative to a standard curve created by serial dilu tion of the mouse positive control cytokine.
Colorimetric liver enzyme assay. Serum ALT was quantified using the ID Labs ALT Enzymatic Assay kit (ID Labs Biotechnology Inc.) as previously described (Bouchlaka et al., 2013) . Colorimetric determination of ALT levels was performed by reading the absorbance of each well at 340 nm on a plate reader (VERSAmax turntable plate reader). The concentration of ALT (U/liter) schedule with the NIH31fortified chow. CR is initiated at 14 wk of age at 10% restriction, increased to 25% restriction at 15 wk, and to 40% restriction at 16 wk of age where it is maintained throughout the life of the animal. In formation on survival curves, food intake curves, and body weights of the NIA strains has been previously published (Turturro et al., 1999) .
All experimental mice were housed in the Animal Facilities at the Uni versity of California, Davis under specific pathogenfree (SPF) conditions. For the comparison in fat volume ratios, young, middleaged, and aged AL and CR mice were ordered and sent to the National Institute on Aging for MRI analysis and also housed under SPF conditions. All of the animal proto cols were approved by the Institutional Animal Care and Use Committees of both institutions. Body weights were also measured for several mice at differ ent ages and on dietary regimens. Mice were euthanized by CO 2 asphyxia tion and the visceral fat pads (mesenteric, gonadal, and renal) were collected and weighed together for each mouse to determine the visceral fat weight.
Reagents. The agonistic anti-mouse CD40 antibody (clone FGK115B3) was generated via ascites production in our laboratory as previously described (Murphy et al., 2003; Bouchlaka et al., 2013) . The endotoxin level of the CD40 was <1 endotoxin unit/mg of antibody as determined by a quantita tive chromogenic limulus amebocyte lysate kit (QCL1000; Bio Whittaker). Recombinant human IL2 (rhIL2; TECIN Teceleukin) was provided by the National Cancer Institute (NCI). Murine CpG ODN 1826 was purchased from InvivoGen. All were injected i.p.
Schedule of CD40/IL-2 and CpG/IL-2 IT treatments. Mice were treated with agonist CD40 antibody and rhIL2 as previously described (Murphy et al., 2003; Bouchlaka et al., 2013) . CD40 or CpG was adminis tered daily for a total of 5 consecutive days (days: 0, 1, 2, 3, and 4) and IL2 was administered twice a day for a total of 4 d (days: 1, 4, 8, and 12). Control mice received rat IgG (rIgG; Jackson ImmunoResearch Laboratories, Inc.) and PBS (Cellgro). Survival was monitored daily. An HD or LD of CD40/ IL2, or HD CpG/IL2, was administered as follows on the same scheduling pattern as previously described (Bouchlaka et al., 2013) : HD CD40/IL2, mice received 80 µg of agonist CD40 and 10 6 IU of IL2 in 0.2 ml PBS i.p.; control mice received 80 µg rIgG in PBS; LD CD40/IL2, mice received 40 µg of agonist CD40 and 4 × 10 5 IU of IL2 in 0.2 ml PBS i.p; control mice received 40 µg rIgG in PBS; CpG/HD IL2, mice received 100 µg CpG ODN 1826 (InvivoGen) and 10 6 IU of IL2 in 0.2 ml PBS i.p.
Macrophage depletion and TNF blockade with etanercept (Enbrel).
In some experiments, mice were in vivo depleted of macrophages using lipo somal clodronate or controlloaded liposomes (Encapsula NanoScience) be fore and during IT administration, as previously described (Bouchlaka et al., 2013) . For experiments where mice were euthanized by day 2 of treatment, 0.2 ml per dose was injected i.p. of either clodronate or control liposomes on days 2 and 0. For all survival experiments, clodronate or control liposomes were administered on days 2, 0, 2, and 4.
TNF blockade was preformed through in vivo subcutaneous injection of 1.5 mg/0.1 ml etanercept (Enbrel) on days 1 and 1 for experiments where mice were euthanized on day 2 of IT therapy. For all survival experiments, etanercept was administered on days 1, 1, 3, 7, and 9. Inflammatory infiltrate in 50% of the triads, which is generally mild, and confined within the portal spaces III: Moderate Inflammatory infiltrate, expanding most or all of the triads, and associated with mild interface and lobular activity IV: Severe
As above for moderate, with spillover into periportal areas and moderate to severe perivenular inflammation that extends into the hepatic parenchyma and is associated with perivenular hepatocyte necrosis normal body temperature using warm air. Mice were inserted into the scan ner in a headfirst prone orientation. Spinecho T1weighted images were obtained through the mouse body (necktobase of the tail) using a 72mm linear volume coil. Scan sequence parameters were the following: TR 1,000 ms, TE 15 ms, and 2 averages. The field of view was 7.7 × 3.85 × 2.0 cm, with a matrix size of 256 × 128 × 40. The corresponding voxel size was 0.3 × 0.3 × 0.5 mm. Images were acquired using ParaVision 5.0 software. After acquisi tion, images were transferred into Invenon Research Workplace 4.0 software (Siemens Preclinical) allowing fat to be displayed with high intensity (white).
Statistical analysis. Statistical analyses were performed using Prism soft ware (GraphPad Software Inc.). Data were expressed as mean ± SEM. For analysis of three or more groups, a nonparametric ANOVA test was per formed with a Bonferroni posthoc test. Analysis of differences between two normally distributed test groups was performed using the Student's t test. Nonparametric groups were analyzed with the MannWhitney test. Welch's correction was applied to datasets with significant differences in variance be fore Student's t test.
Histopathology and grading/scoring. Liver and whole intestines were collected on day 2 of IT, flushed, and fixed in 10% paraformaldehyde, embed ded in paraffin, cut into 5µm sections, and stained with hematoxylin and eosin (H&E). All tissues were prepared and stained at Histology Consultation Services, Inc. (Everson, WA). Images were captured with a microscope (BX4; Olympus) equipped with a Qcolor3 camera and 10× numerical aperture objective lens. Magnification for each captured image is specified in the figure legends. Grading of histopathological inflammation was performed using a scale from 0 to 4 in a blind fashion by a boardcertified pathologist (M. Chen) at the UC Davis Medical Center's Department of Pathology and Laboratory Medicine. Specifically, the grading score for liver and gastrointestinal tract followed our previously published grading method (Bouchlaka et al., 2013) , summarized in Tables 1 and 2. MRI. To quantify abdominal fat, MR images were acquired in collaboration with the National Institute on Aging. Images were acquired using a Biospec 7 Tesla 30cm MRI scanner (Bruker Biospin) with a 72mm diameter transmit receive birdcage coil. In each experiment, two mice were inserted into the scanner, side by side, in feetfirst prone orientation immediately after sacrifice. During scanning, the mice were cooled with a stream of cold air from a vortex tube (Exair, Inc.) to minimize decomposition. Two different pulse sequences were used: a heavily T1weighted fast spin echo (RARE) sequence yielding brightfat (watersuppressed [WS]) images and a fatsuppressed proton density weighted fast gradient echo (FLASH) sequence yielding fatsuppressed (FS) images. 3D datasets were acquired in axial orientation with a field of view of 72 × 36 × 80 mm (leftright × anteriorposterior × headfoot) and matrix size 256 × 128 × 128. The voxel size (spatial resolution) was 281 × 281 × 625 µm. The spectral bandwidth in both sequences was 100 kHz (391 Hz/pixel) and two averages were acquired for improved signaltonoise ratio. For the RARE sequence, the RARE factor (i.e., number of spin echoes per shot or number of kspace lines per segment) was 8, the repetition time (TR) was 125 ms, the actual echo time (TE) was 11.4 ms, and the effective echo time (TEeff) was 46.3 ms. Each RARE scan took 8 min and 32 s to acquire. For the FLASH sequence, the repetition time was 25 ms and the echo time was 3.2 ms. The excitation pulse had a flip angle of 30°. Each FLASH scan took 13 min 39 s to acquire. Image processing was performed in ImageJ 1.45 (NIH). The statisti cal analyses were performed using oneway ANOVA and the NewmanKeuls posthoc test. P < 0.05 was considered to be significant. To visualize fat distribution and content imaging of young ob/ob, DIO, and lean agematched controls were conducted in collaboration with the Center for Molecular and Genomic Imaging (CMGI) Facility at the Univer sity of California, Davis. Mice were anesthetized before imaging using 2% isoflurane in an induction chamber and then maintained on 1-2% isoflurane throughout imaging via a nose cone fitted for anesthetic inhalation. Mice were imaged using a BioSpec 70/30 7T (Bruker Biospin) horizontal bore system designed specifically for small animal imaging. Animals were kept at Inflammatory infiltrate in 50% of the crypts, which is generally mild, and confined within the mucosa epithelium with mild architectural distortion III: Moderate Inflammatory infiltrate involving most of the crypts, and associated with architectural distortion (villous blunting and focal mucosal atrophy/erosion) and luminal inflammatory exudate IV: Severe Extensive inflammatory infiltrate (large lymphoid aggregates) with expanding into the lamina/muscular propria, and associated with prominent mucosal ulceration/denuding, muscular wall necrosis, and/or perforation
